Northwestern Mutual Wealth Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-78
| Closed | -$964 | – | 4222 |
|
|
2025
Q4 | $964 | Buy |
+78
| New | +$836 | ﹤0.01% | 3640 |
|
|
2025
Q3 | – | Sell |
-1
| Closed | -$6 | – | 3867 |
|
|
2025
Q2 | $6 | Sell |
1
-9
| -90% | -$52 | ﹤0.01% | 3636 |
|
|
2025
Q1 | $49 | Buy |
+10
| New | +$83 | ﹤0.01% | 3582 |
|
|
2023
Q4 | – | Sell |
-56
| Closed | -$190 | – | 3522 |
|
|
2023
Q3 | $190 | Buy |
+56
| New | +$310 | ﹤0.01% | 3182 |
|
|
2022
Q4 | – | Sell |
-92
| Closed | -$2K | – | 3354 |
|
|
2022
Q3 | $2K | Hold |
92
| – | – | ﹤0.01% | 2867 |
|
|
2022
Q2 | $3K | Sell |
92
-90
| -49% | -$3.07K | ﹤0.01% | 2828 |
|
|
2022
Q1 | $7K | Sell |
182
-2,083
| -92% | -$91.9K | ﹤0.01% | 2627 |
|
|
2021
Q4 | $98K | Buy |
2,265
+2,173
| +2,362% | +$98.3K | ﹤0.01% | 1719 |
|
|
2021
Q3 | $5K | Hold |
92
| – | – | ﹤0.01% | 2660 |
|
|
2021
Q2 | $6K | Sell |
92
-21
| -19% | -$1.35K | ﹤0.01% | 2584 |
|
|
2021
Q1 | $11K | Buy |
113
+21
| +23% | +$2.15K | ﹤0.01% | 2252 |
|
|
2020
Q4 | $8K | Hold |
92
| – | – | ﹤0.01% | 2257 |
|
|
2020
Q3 | $10K | Hold |
92
| – | – | ﹤0.01% | 1985 |
|
|
2020
Q2 | $7K | Hold |
92
| – | – | ﹤0.01% | 1995 |
|
|
2020
Q1 | $5K | Hold |
92
| – | – | ﹤0.01% | 2066 |
|
|
2019
Q4 | $5K | Hold |
92
| – | – | ﹤0.01% | 2062 |
|
|
2019
Q3 | $5K | Hold |
92
| – | – | ﹤0.01% | 2091 |
|
|
2019
Q2 | $4K | Hold |
92
| – | – | ﹤0.01% | 2155 |
|
|
2019
Q1 | $5K | Hold |
92
| – | – | ﹤0.01% | 2127 |
|
|
2018
Q4 | $5K | Hold |
92
| – | – | ﹤0.01% | 2027 |
|
|
2018
Q3 | $6K | Buy |
+92
| New | +$5.37K | ﹤0.01% | 2052 |
|
|
2018
Q1 | – | Sell |
-48
| Closed | -$2K | – | 2234 |
|
|
2017
Q4 | $2K | Buy |
+48
| New | +$2.02K | ﹤0.01% | 2079 |
|
|
2017
Q1 | – | Sell |
-31
| Closed | -$1K | – | 2098 |
|
|
2016
Q4 | $1K | Buy |
+31
| New | +$929 | ﹤0.01% | 2153 |
|
|
2016
Q3 | – | Sell |
-83
| Closed | -$2K | – | 532 |
|
|
2016
Q2 | $2K | Sell |
83
-222
| -73% | -$8.7K | ﹤0.01% | 1827 |
|
|
2016
Q1 | $12K | Buy |
+305
| New | +$10.8K | ﹤0.01% | 1363 |
|
|
2015
Q1 | – | Sell |
-74
| Closed | -$2K | – | 1605 |
|
|
2014
Q4 | $2K | Buy |
+74
| New | +$1.76K | ﹤0.01% | 1495 |
|
Other funds holding EBS
VCM
PCM
VPM
Northwestern Mutual Wealth Management's EBS Position: Q1 2026 in Review
Northwestern Mutual Wealth Management sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 78 shares — an estimated $964 sold.
Northwestern Mutual Wealth Management first reported a position in EBS in Q4 2014 and held it in 26 quarters. The position peaked at $98K in Q4 2021. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Northwestern Mutual Wealth Management reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 78 Emergent Biosolutions shares in Q1 2026, an estimated $964.
- Northwestern Mutual Wealth Management first reported a position in Emergent Biosolutions in Q4 2014 and held it in 26 quarters.
- Northwestern Mutual Wealth Management's Emergent Biosolutions position peaked at $98K in Q4 2021.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.